Role_NN
of_IN
Egr-2_NN
in_IN
up-regulation_NN
of_IN
Fas_NN
ligand_NN
in_IN
normal_JJ
T_NN
cells_NNS
and_CC
aberrant_JJ
double-negative_JJ
lpr_NN
and_CC
gld_NN
T_NN
cells_NNS
._.

We_PRP
previously_RB
identified_VBD
a_DT
Fas_NN
ligand_NN
regulatory_JJ
element_NN
-LRB-_-LRB-
FLRE_NN
-RRB-_-RRB-
in_IN
the_DT
Fas_NN
ligand_NN
-LRB-_-LRB-
fasL_NN
-RRB-_-RRB-
promoter_NN
that_WDT
binds_VBZ
Egr_NN
family_NN
proteins_NNS
and_CC
demonstrated_VBD
that_IN
Egr-3_NN
-LRB-_-LRB-
PILOT_NN
-RRB-_-RRB-
but_CC
not_RB
Egr-1_NN
-LRB-_-LRB-
NGFI-A_NN
,_,
Krox-24_NN
,_,
Tis-8_NN
,_,
and_CC
Zif-268_NN
-RRB-_-RRB-
induces_VBZ
transcription_NN
of_IN
fasL_NN
._.

The_DT
aberrant_JJ
CD4_NN
-LRB-_-LRB-
-_NN
-RRB-_-RRB-
CD8_NN
-LRB-_-LRB-
-_NN
-RRB-_-RRB-
T_NN
cells_NNS
from_IN
lpr\/lpr_NN
and_CC
gld\/gld_NN
mice_NNS
,_,
which_WDT
have_VBP
mutations_NNS
in_IN
the_DT
genes_NNS
encoding_VBG
Fas_NN
and_CC
FasL_NN
,_,
respectively_RB
,_,
have_VBP
an_DT
activated_VBN
phenotype_NN
and_CC
constitutively_RB
express_VBP
high_JJ
levels_NNS
of_IN
fasL_NN
mRNA_NN
,_,
prompting_VBG
us_PRP
to_TO
ask_VB
what_JJ
role_NN
if_IN
any_DT
the_DT
FLRE_NN
and_CC
Egr_NN
family_NN
proteins_NNS
have_VBP
in_IN
this_DT
aberrant_JJ
expression_NN
of_IN
fasL_NN
._.

Unstimulated_JJ
MRL-lpr\/lpr_NN
and_CC
C3H-gld\/gld_JJ
CD4_NN
-LRB-_-LRB-
-_NN
-RRB-_-RRB-
CD8_NN
-LRB-_-LRB-
-_NN
-RRB-_-RRB-
T_NN
cells_NNS
constitutively_RB
contained_VBD
high_JJ
levels_NNS
of_IN
two_CD
proteins_NNS
that_WDT
bound_VBN
to_TO
the_DT
FLRE_NN
._.

Supershift_NN
analysis_NN
revealed_VBD
these_DT
proteins_NNS
to_TO
be_VB
Egr-1_NN
and_CC
Egr-2_NN
-LRB-_-LRB-
Krox-20_NN
-RRB-_-RRB-
;_:
Egr-3_NN
was_VBD
not_RB
detected_VBN
._.

Activation_NN
of_IN
normal_JJ
lymph_NN
node_NN
cells_NNS
resulted_VBD
in_IN
increased_VBN
expression_NN
of_IN
Egr-1_NN
,_,
-2_CD
,_,
and_CC
-3_CD
._.

As_IN
with_IN
egr-3_NN
,_,
expression_NN
of_IN
egr-2_NN
was_VBD
blocked_VBN
by_IN
cyclosporin_NN
A_NN
._.

Although_IN
overexpressed_VBN
Egr-1_NN
was_VBD
ineffective_JJ
,_,
overexpressed_VBN
Egr-2_NN
was_VBD
as_RB
potent_JJ
as_IN
Egr-3_NN
in_IN
inducing_VBG
fasL_NN
promoter-dependent_JJ
reporter_NN
constructs_NNS
in_IN
T_NN
cell_NN
hybridomas_NNS
and_CC
HeLa_NN
cells_NNS
,_,
and_CC
both_DT
up-regulated_VBD
endogenous_JJ
fasL_NN
mRNA_NN
in_IN
HeLa_NN
cells_NNS
._.

FasL-dependent_JJ
reporter_NN
constructs_NNS
in_IN
MRL-lpr\/lpr_NN
and_CC
C3H-gld\/gld_JJ
CD4_NN
-LRB-_-LRB-
-_NN
-RRB-_-RRB-
CD8_NN
-LRB-_-LRB-
-_NN
-RRB-_-RRB-
T_NN
cells_NNS
were_VBD
constitutively_RB
active_JJ
,_,
and_CC
this_DT
activity_NN
was_VBD
largely_RB
prevented_VBN
by_IN
mutation_NN
of_IN
the_DT
critical_JJ
Egr_NN
family_NN
binding_NN
element_NN
._.

Thus_RB
,_,
Egr-2_NN
,_,
in_IN
addition_NN
to_TO
Egr-3_NN
,_,
regulates_VBZ
FasL_NN
expression_NN
in_IN
activated_VBN
normal_JJ
T_NN
cells_NNS
,_,
and_CC
Egr-2_NN
is_VBZ
likely_JJ
to_TO
play_VB
a_DT
direct_JJ
role_NN
in_IN
aberrant_JJ
fasL_NN
up-regulation_NN
in_IN
lpr\/lpr_NN
and_CC
gld\/gld_NN
CD4_NN
-LRB-_-LRB-
-_NN
-RRB-_-RRB-
CD8_NN
-LRB-_-LRB-
-_NN
-RRB-_-RRB-
T_NN
cells_NNS
._.

